VolitionRx Ltd
VNRX
34 hedge funds and large institutions have $8.02M invested in VolitionRx Ltd in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.
282% more call options, than puts
Call options by funds: $172K | Put options by funds: $45K
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
10% more funds holding
Funds holding: 31 → 34 (+3)
0.04% less ownership
Funds ownership: 0.55% → 0.51% (-0.04%)
34% less capital invested
Capital invested by funds: $12.2M → $8.02M (-$4.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$279K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$148K |
| 3 |
VF
Virtu Financial
New York
|
+$71K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$65K |
| 5 |
CPA
Cowen Prime Advisors
New York
|
+$39.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
-$328K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$217K |
| 3 |
SAMC
Spectrum Asset Management (California)
Newport Beach,
California
|
-$114K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$51K |
| 5 |
Millennium Management
New York
|
-$36.1K |
VNRX Hedge Fund Activity: Q3 2022 in Review
34 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2022, worth a combined $8.02M — down 34% from $12.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new VNRX positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Bank Julius Baer & Co, opening a new position worth an estimated $279K. The largest seller was Lagoda Investment Management, cutting an estimated $328K.
- 34 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2022, up from 31 in Q2 2022.
- Funds reported $8.02M of VolitionRx Ltd stock for Q3 2022, down 34% quarter-over-quarter.
- 6 funds opened new VolitionRx Ltd positions in Q3 2022 and 3 closed out, a net change of +3 holders.
- The largest VolitionRx Ltd buyer in Q3 2022 was Bank Julius Baer & Co, an estimated $279K added.
- The largest VolitionRx Ltd seller in Q3 2022 was Lagoda Investment Management, an estimated $328K sold.
Based on aggregated 13F filings for Q3 2022.